Delivery Order SPE2DB24D2205-SPE2DB25FEFBQ
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,253.69 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $5,190.53 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $43,249.13 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used in the treatment of overactive...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $13,069.24 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of January 9, 2024, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Gemtesa 75 mg tablets. The contract is valued at $5,111.05 and has an ultimate completion date of August 8, 2024. It is a firm-fixed-price contract for the delivery of this pharmaceutical product. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set-aside for any specific business type. The contract is...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $71,258.34 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of GEMTESA 75 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for delivering a comprehensive range of pharmaceutical and medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gemtesa 75 mg tablets in quantities of 90, with a total ceiling value of $8,669.82 and a final completion date of July 3, 2025. The contract is not set aside and was awarded on July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $17,347.46 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp for the supply of GEMTESA 75 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that enables the DLA to procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,101.12, is for the delivery of Gemtesa 75 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,601.91, is for the delivery of Gemtesa 75 mg tablets over a period ending on July 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...